COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Monday 27 July 2020
Only two of the 27 COVID VACCINE STOCKS have lost money since March 1
Generex Biotechnology is still the poorest performer of the 27 COVID VACCINE STOCKS since March 1.
Overall these stocks have returned 215% since then. Only two stocks have lost money: Generex and Nano Viricides.
No comments:
Post a Comment